[Investigation of atherosclerosis in postmenopausal women: alteration of atherosclerosis-associated factors and vascular atherosclerosis by oral and transdermal estrogen replacement].
Maebashi, Japan. In Rinsho Byori, 2013
We evaluated the effects of oral conjugated equine estrogen (CEE) therapy and transdermal estradiol(E2) therapy on atherosclerosis-associated factors, such as circulating lipids, glucose, insulin, uric acid, and vascular inflammatory markers, and the vascular atherosclerosis assessment test, including blood pressure, brachial artery flow-mediated vasodilatation (FMD), brachial-ankle pulse wave velocity (baPWV), and carotid intima-media thickness (IMT), in postmenopausal women.
Chemically engineered extracts: source of bioactive compounds.
Rosario, Argentina. In Acc Chem Res, 2011
We isolated a semisynthetic β-glucosidase inhibitor from a CEE prepared by reaction with benzenesulfonyl chloride, an antifungal pyrazole from a CEE prepared by reaction with hydrazine, and an acetylcholinesterase inhibitor from a CEE prepared through bromination.